Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development
Rabies is an ancient neurological disease that is almost invariably fatal once the clinical symptoms develop. Currently, prompt wound cleansing after exposing to a potentially rabid animal and vaccination using rabies vaccine combined with administration of rabies immune globulin are the only effective methods for post-exposure prophylaxis against rabies. Reverse genetic technique is a novel approach to investigate the function of a specific gene by analyzing the phenotypic effects through directly manipulating the gene sequences. It has revolutionized and provided a powerful tool to study the molecular biology of RNA viruses and has been widely used in rabies virus research. The attenuation of rabies virus virulence is the prerequisite for rabies vaccine development. Given the current challenge that sufficient and affordable high-quality vaccines are limited and lacking for global rabies prevention and control, highly cell-adapted, stable, and attenuated rabies viruses with broad cross-reactivity against different viral variants are ideal candidates for consideration to meet the need for human rabies control in the future. A number of approaches have been pursued to reduce the virulence of the virus and improve the safety of rabies vaccines. The application of reverse genetic technique has greatly advanced the engineering of rabies virus and paves the avenue for utilizing rabies virus for vaccine against rabies, viral vectors for exogenous antigen expression, and gene therapy in the future.
KeywordsRabies virus Reverse genetic technique Attenuation Vaccine
We acknowledge support from Pres. Jincai Wang (Shenzhen Weiguang Biological Products Co., Ltd). This work was financially supported by Guangdong Engineering Research and Development Center.
Conflict of interest
The authors declare that they have no competing interests.
- Abraham G, Banerjee AK Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A 73: 1504–1508Google Scholar
- Barkhouse DA, Garcia SA, Bongiorno EK, Lebrun A, Faber M, Hooper DC (2014) Expression of IFNγ by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. J VirolGoogle Scholar
- Briggs DJ, Nagarajan T, Rupprecht CE (2013) Rabies vaccines. In: Jackson A (eds) Rabies, 3rd edn. Elsevier Inc, pp 497–526Google Scholar
- Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMedCentralPubMedGoogle Scholar
- Conzelmann K-K (2013) Reverse genetics of Mononegavirales: The rabies virus paradigm. In: Nagai Y (eds) Sendai virus vector: Advantages and applications, 1st edn. Springer, pp 1–20Google Scholar
- Faber M, Bette M, Preuss MA, Pulmanausahakul R, Rehnelt J, Schnell MJ, Dietzschold B, Weihe E (2005a) Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J Virol 79:15405–15416PubMedCentralPubMedCrossRefGoogle Scholar
- Ito H, Minamoto N, Watanabe T, Goto H, Rong LT, Sugiyama M, Kinjo T, Mannen K, Mifune K, Konobe T, Yoshida I, Takamizawa A (1994) A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan. Microbiol Immunol 38:479–482PubMedCrossRefGoogle Scholar
- Jacobsen H, Mestan J, Mittnacht S, Dieffenbach CW (1989) Beta interferon subtype 1 induction by tumor necrosis factor. Mol Biol Cell 9:3037–3042Google Scholar
- McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ (2003) Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. J Virol 77:237–244PubMedCentralPubMedCrossRefGoogle Scholar
- Rupprecht CE, Plotkin SA (2013) Rabies vaccines. In Plotkin SA, Orenstein WA, Offit PA (eds) Vaccines, 6th edn. Elsevier Inc, pp 646–668Google Scholar
- Zhao W, Zhang ZY, Zsak L, Yu QZ (2014) P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression. doi: 10.1099/vir.0.068437-0